The SWEET Project 10-Year Benchmarking in 19 Countries Worldwide Is Associated with Improved HbA1c and Increased Use of Diabetes Technology in Youth with Type 1 Diabetes

Autor: Gun Forsander, Anke Schwandt, Michael Witsch, Peter Gerhardsson, Tadej Battelino, O Kordonouri, H. J. Veeze, Thomas Danne, Jannet Svensson

Publikováno v: Gerhardsson, P, Schwandt, A, Witsch, M, Kordonouri, O, Svensson, J, Forsander, G, Battelino, T, Veeze, H & Danne, T 2021, ' The SWEET Project 10-Year Benchmarking in 19 Countries Worldwide Is Associated with Improved HbA1c and Increased Use of Diabetes Technology in Youth with Type 1 Diabetes ', Diabetes Technology and Therapeutics, vol. 23, no. 7, pp. 491-499 . https://doi.org/10.1089/dia.2020.0618
Diabetes technology & therapeutics, vol. 23, no. 7, pp. 491-499, 2021.

Objective: The international SWEET registry (NCT04427189) was initiated in 2008 to improve outcomes in pediatric diabetes. A 10-year follow-up allowed studying time trends of key quality indicators in 22 centers from Europe, Australia, Canada, and In

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f321c88ad42b84e7ee03a85157161e0
https://pubmed.ncbi.nlm.nih.gov/33566729

Possibilities and challenges of a large international benchmarking in pediatric diabetology-The SWEET experience

Autor: Guy T. Alonso, Ragnar Hanas, Zdenek Sumnik, H. J. Veeze, Olga Kordonouri, João Filipe Raposo, Anke Schwandt, Ioanna Kosteria, Stephane Besancon, Michael Witsch, Valentino Cherubini, Dhruvi Hasnani, Natasa Bratina, Margarita Archinkova, Niels H Birkebaek, Jannet Svensson, Violeta Iotova

Publikováno v: Witsch, M, Kosteria, I, Kordonouri, O, Alonso, G, Archinkova, M, Besancon, S, Birkebæk, N H, Bratina, N, Cherubini, V, Hanas, R, Hasnani, D, Iotova, V, Raposo, J F, Schwandt, A, Sumnik, Z, Svensson, J, Veeze, H & SWEET Group 2016, ' Possibilities and challenges of a large international benchmarking in pediatric diabetology-The SWEET experience ', Pediatric Diabetes, vol. 17 Suppl 23, pp. 7-15 . https://doi.org/10.1111/pedi.12432

AIM: Despite the existence of evidence-based guidelines for the care of children with diabetes, widespread gaps in knowledge, attitude, and practice remain. The purpose of this paper is to present a review of benchmarking practices and results of thi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cde45a274d7d1f200df725d984e1b59
https://doi.org/10.1111/pedi.12432

Glycaemic control of Type 1 diabetes in clinical practice early in the 21st century: an international comparison

Autor: Ieva Strele, Sarah H. Wild, Henk-Jan Aanstoot, Mykola Khalangot, Maxine Lamb, H. J. Veeze, Elizabeth A. Davis, Alexandra Bargiota, Thomas Almdal, Kellee M. Miller, Sabine E. Hofer, Stelios Tigas, Justin T. Warner, J.G. Cooper, Wolfram Karges, Robert I. M. Young, Sean F. Dinneen, Ann-Marie Svensson, Rosaria Gesuita, P.F. Souchon, Kirsten J Coppell, Maria Fritsch, Jannet Svensson, Santa Pildava, William V. Tamborlane, Valentino Cherubini, Mark E. Cooper, Timothy W. Jones, Katarina Eeg-Olofsson, Reinhard W. Holl, John A. McKnight, C. Sampanis, S Gudbjornsdottir, D.M. Kieninger, Gregory A. Magee, Edith Schober, B. Delemer

Publikováno v: Diabetic Medicine. 32:1036-1050

AimsImproving glycaemic control in people with Type1 diabetes is known to reduce complications. Our aim was to compare glycaemic control among people with Type1 diabetes using data gathered in regional or national registries. MethodsData were obtaine

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7344351383553b705e7a06a3f8f5f036
https://doi.org/10.1111/dme.12676

Revisiting infant growth prior to childhood onset type 1 diabetes

Autor: G.J. Bruining, Aan V. Kharagjitsingh, Bart O. Roep, M. A. J. de Ridder, Bobby P. C. Koeleman, H. J. Veeze

Publikováno v: Clinical Endocrinology, 72(5), 620-624. Wiley-Blackwell Publishing Ltd
Clinical Endocrinology, 72(5), 620-624

P>Objective Accelerated early growth prior to childhood type 1 diabetes onset is associated with an increased risk for type 1 diabetes (T1D). We aimed to study early growth, correcting for the previously neglected confounder of familial effects. Desi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a8c8a281f42c671992e66a041005687
https://hdl.handle.net/1765/27988

Cystic fibrosis transmembrane conductance regulator (CFTR)-mediated residual chloride secretion does not protect against early chronic pseudomonas aeruginosa infection in F508del homozygous cystic fibrosis patients

Autor: Horst von der Hardt, Manfred Ballmann, Inez Bronsveld, Nico Derichs, Burkhard Tümmler, J. Bijman, Frauke Mekus, H. J. Veeze

Publikováno v: Pediatric Research, 55(1), 69-75. Lippincott Williams & Wilkins

Cystic fibrosis (CF) disease severity is characterized by a broad variability that has been attributed, in addition to the CF transmembrane conductance regulator (CFTR) genotype, to modulating factors such as CFTR-mediated residual chloride (Cl-) sec

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6270ad15bf8a76df027150a15bb8d1a1
https://doi.org/10.1203/01.pdr.0000100758.66805.ce